Reuters - Hospira Inc. , which makes specialty pharmaceuticals and medication-delivery systems, on Wednesday said quarterly earnings fell 25 percent as sales were nearly flat and expenses surged.

Reuters - Barr Pharmaceuticals Inc. aims to resubmit its application to sell its Plan B morning-after contraceptive pill within two weeks, the company said on Tuesday, following a meeting with U.S. Food and Drug Administration officials.

Reuters - The U.S. Food and Drug Administration and Barr Pharmaceuticals Inc. will meet to discuss the possible approval of nonprescription sales of the Plan B "morning-after" contraceptive to women 18 and older, the agency said on Monday.

Reuters - The U.S. Food and Drug Administration will meet with officials from Barr Pharmaceuticals Inc. to discuss the possible approval of nonprescription sales of the Plan B "morning-after" contraceptive to women 18 and older, the agency said on Monday.

Reuters - AstraZeneca Plc has won U.S. approval for its asthma drug Symbicort, significantly earlier than most industry analysts had expected, a person familiar with the matter said on Saturday.

Reuters - U.S. drug maker Barr Pharmaceuticals has entered the bidding for Croatian pharmaceutical group Pliva (PLVxq.L), the Financial Times newspaper said on Monday.

Reuters - Barr Pharmaceuticals Inc. on Thursday said Eli Lilly & Co. has sued the company, claiming Barr's generic weekly form of anti-depressant Prozac infringes the patent on Lilly's branded medicine.

Europe's biggest pharmaceuticals manufacturer, GlaxoSmithKline, says shareholders were told they would have their details posted on the internet if they did not sell their shares within 14 days in a threatening letter by animal rights...

Ariad Pharmaceuticals Inc. shares climbed up to 40 percent on Thursday after the company announced it won a patent infringement case against Eli Lilly and Co. Reuters reports a federal court in Massachusetts decided that Lilly's osteoporosis...

Reuters - Attorneys suing Merck & Co. Inc. for the death of a 71-year-old man who took Vioxx asked a Texas jury on Thursday to award more than $1 billion in damages, but Merck lawyers said the pharmaceuticals company should not have to pay anything.

Reuters - Pharmaceuticals distributor DrugMax Inc. reported preliminary results for the first quarter on Monday.

Reuters - Cortex Pharmaceuticals Inc. shares lost almost half of their value in morning trade Monday after the U.S. Food and Drug Administration placed the clinical trial of the company's sleep disorder drug on hold.

Reuters - SGX Pharmaceuticals Inc. late on Monday said Swiss drugmaker Novartis AG had licensed its experimental drugs to treat leukemia and could eventually pay it more than $515 million under the deal.

Reuters - King Pharmaceuticals, Inc. on Friday said U.S. regulators have determined that clinical data on use by children of its Altace hypertension drug was insufficient and a new trial may be needed.

Reuters - British drugmaker Shire Plc said on Friday it was suing Teva Pharmaceuticals over the Israeli drugmaker's plans to make a cheap, copycat version of hyperactivity drug Adderall XR.

Reuters - Drugmaker King Pharmaceuticals Inc. on Tuesday posted a quarterly loss after taking a large charge tied to a research deal.